je.st
news
Tag: data presented
Merck Announces that IMPROVE-IT Achieved Primary Endpoint; Data to be Presented at American Heart Association Scientific Sessions Today
2014-11-17 14:30:00| Merck.com - Product News
Dateline City: WHITEHOUSE STATION, N.J. Data are Embargoed by American Heart Association until 10:45 AM CT Today WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today said that IMPROVE-IT met its primary endpoint. The results are scheduled to be presented at the American Heart Association Scientific Sessions later today. The data are embargoed by the American Heart Association until the start of the late-breaking clinical trials session at 10:45 a.m. CT today. About Merck Language: English Contact: MerckMedia Contact:Pam Eisele, 267-305-3558orInvestor Contact:Joe Romanelli, 908-423-5185 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: data
today
american
primary
UK data presented at EURETINA 2014 showcase efficacy of EYLEA in...
2014-10-05 15:23:30| Chemicals - Topix.net
Bayer HealthCare reports that data have been presented at the 14th EURETINA congress in London, showcasing the efficacy of EYLEA for the treatment of wet age-related macular degeneration in the real-life setting. Numerous posters presented at the congress, from centres across the UK, highlight that treatment with EYLEA has resulted in improved visual and / or anatomical outcomes in treatment-naive and pre-treated patients.1-4 Commenting on the data, Luis-Felipe Graterol, Medical Director, Bayer HealthCare said, 'It is encouraging to see that the efficacy seen in the clinical trials for Eylea is being reflected in clinical practice and that patients are benefitting from this treatment across the country.
Tags: in
data
presented
showcase
New Data about ZILMAX Being Presented at 2014 ADSA-ASAS-CSAS Joint Annual Meeting
2014-07-22 19:21:23| Beef
Merck Animal Health, known as MSD Animal Health outside the United States and Canada, announced that new studies about ZILMAX® (zilpaterol hydrochloride), an FDA-approved feed supplement for cattle, will be presented at the Joint Annual Meeting of the American Society of Animal Science, American Dairy Science Association and Canadian Society of Animal Science, July 20 – 24, 2014, in Kansas City, Missouri. The studies were conducted by third-party investigators. read more
Tags: data
presented
meeting
annual
Novel Hydrogel Sealant And Sustained Release Drug Technology Data To Be Presented At The ASCRS Annual Symposium
2014-04-21 10:33:31| chemicalonline News Articles
Ocular Therapeutix, Inc., developers of ophthalmic therapeutic products using a proprietary hydrogel technology, has announced that 11 podium and poster presentations, including clinical data on its ReSure Sealant and sustained release dexamethasone, will be presented at the upcoming American Society of Cataract and Refractive Surgery (ASCRS) Annual Symposium in Boston, Massachusetts from April 25-29, 2014
Tags: the
data
technology
release
Enanta Pharmaceuticals Announces New Data Presented On Protease Inhibitor ABT-493 At The 21st Conference On Retroviruses And Opportunistic Infections (CROI)
2014-03-05 04:59:35| drugdiscoveryonline Home Page
Enanta Pharmaceuticals, Inc., a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, recently announced that new in vitro data on ABT-493, a potent NS3/4 protease inhibitor, was presented today during a poster session at the 21st Conference on Retroviruses and Opportunistic Infections (CROI) in Boston
Tags: data
presented
conference
21st